Anish Suri - Net Worth and Insider Trading

Anish Suri Net Worth

The estimated net worth of Anish Suri is at least $185,146 dollars as of 2024-04-28. Anish Suri is the PRESIDENT AND CSO of Cue Biopharma Inc and owns about 135,638 shares of Cue Biopharma Inc (CUE) stock worth over $185,146. Details can be seen in Anish Suri's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Anish Suri has not made any transactions after 2023-08-25 and currently still holds the listed stock(s).

Transaction Summary of Anish Suri

To

Anish Suri Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Anish Suri owns 1 companies in total, including Cue Biopharma Inc (CUE) .

Click here to see the complete history of Anish Suri’s form 4 insider trades.

Insider Ownership Summary of Anish Suri

Ticker Comapny Transaction Date Type of Owner
CUE Cue Biopharma Inc 2023-08-25 President and CSO

Anish Suri Latest Holdings Summary

Anish Suri currently owns a total of 1 stock. Anish Suri owns 135,638 shares of Cue Biopharma Inc (CUE) as of August 25, 2023, with a value of $185,146.

Latest Holdings of Anish Suri

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CUE Cue Biopharma Inc 2023-08-25 135,638 1.37 185,146

Holding Weightings of Anish Suri


Anish Suri Form 4 Trading Tracker

According to the SEC Form 4 filings, Anish Suri has made a total of 6 transactions in Cue Biopharma Inc (CUE) over the past 5 years, including 1 buys and 5 sells. The most-recent trade in Cue Biopharma Inc is the acquisition of 4,000 shares on August 25, 2023, which cost Anish Suri around $11,040.

Insider Trading History of Anish Suri

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Anish Suri Trading Performance

GuruFocus tracks the stock performance after each of Anish Suri's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Anish Suri is 37.55%. GuruFocus also compares Anish Suri's trading performance to market benchmark return within the same time period. The performance of stocks bought by Anish Suri within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Anish Suri's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Anish Suri

Average Return

250.33%

Average return per transaction

Outperforming Transactions

100%

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 3.2 37.55 17.37 250.33 68.52 35.51
Relative Return to S&P 500(%) -1.29 26.74 -1.43 217.04 44.9 11.16

Anish Suri Ownership Network

Ownership Network List of Anish Suri

No Data

Ownership Network Relation of Anish Suri


Anish Suri Owned Company Details

What does Cue Biopharma Inc do?

Who are the key executives at Cue Biopharma Inc?

Anish Suri is the President and CSO of Cue Biopharma Inc. Other key executives at Cue Biopharma Inc include director & CEO Daniel R Passeri , Chief Medical Officer Matteo Levisetti , and Chief Business Officer Patricia Nasshorn .

Cue Biopharma Inc (CUE) Insider Trades Summary

Over the past 18 months, Anish Suri made 1 insider transaction in Cue Biopharma Inc (CUE) with a net purchase of 4,000. Other recent insider transactions involving Cue Biopharma Inc (CUE) include a net sale of 9,325 shares made by Peter A Kiener , a net purchase of 3,000 shares made by Daniel R Passeri ,

In summary, during the past 3 months, insiders sold 0 shares of Cue Biopharma Inc (CUE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 9,325 shares of Cue Biopharma Inc (CUE) were sold and 7,000 shares were bought by its insiders, resulting in a net sale of 2,325 shares.

Cue Biopharma Inc (CUE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cue Biopharma Inc Insider Transactions

No Available Data

Anish Suri Mailing Address

Above is the net worth, insider trading, and ownership report for Anish Suri. You might contact Anish Suri via mailing address: 40 Guest Street, Boston Ma 02135.

Discussions on Anish Suri

No discussions yet.